Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole (Q34327868)
scientific article
Language:
(P31) (Q13442814)
(P304) 601-607
(P407) (Q1860)
(P433) 6 Pt 1
(P478) 56
(P577) Thursday, December 1, 1994
(P1433) (Q1101529)
(P1476) "Oral triazolam is potentially hazardous to patients receiving systemic antimycotics ketoconazole or itraconazole." (language: en)
(P2093) Varhe A
Olkkola KT
Neuvonen PJ
other details
description scientific article

External Links